氧气驱动联合雾化吸入治疗慢性支气管炎临床疗效观察

Clinical Observation on Oxygen Inhalation Combined With Aerosol Inhalation in the Treatment of Chronic Bronchitis

目的探究在氧气驱动下使用特布他林联合布地奈德雾化使患者吸入来治疗慢性支气管炎对患者所产生的临床疗效。方法选取2017年1—12月在我院治疗的慢性支气管炎患者68例作为研究对象,将其随机分为两组。对照组采用常规治疗,观察组采用雾化治疗,对比两组患者的疗效。结果观察组患者的住院时间为(3.05±1.49)d,短于对照组;观察组患者的治疗总有效率为94.12%,高于对照组,组间各数据对比,差异均具有统计学意义(P<0.05);观察组患者的不良反应发生率为5.88%,低于对照组,差异具有统计学意义(P<0.05)。结论采取氧气驱动下特布他林联合布地奈德雾化辅助常规治疗慢性支气管炎疗效显著且安全性高。

Objective To explore the clinical efficacy of the treatment of chronic bronchitis by inhalation of terbutaline and budesonide under oxygen-driven therapy. Methods A total of 68 patients with chronic bronchitis treated in our hospital from January to December 2017 were selected as the study objects and they were randomly divided into two groups. The control group received routine treatment. The observation group was treated with atomization and the efficacy of the two groups was compared. Results The hospitalization time of the observation group was（3.05±1.49） d, shorter than that of the control group. The total effective rate of the observation group was 94.12%, which was higher than that of the control group, and the difference between the groups was statistically significant（P 〈0.05）. The incidence of adverse reactions in the observation group was 5.88%, lower than that in the control group, and the difference was statistically significant（P 〈0.05）. Conclusion The use of oxygendriven terbutaline combined with budesonide in the treatment of chronic bronchitis is effective and safe.